EVM
BIVV

Eaton Vance Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Eaton Vance Management’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-103,253
Closed -$5.57M – 1174
2017
Q4 		$5.57M Sell
103,253
-1,577
-2% -$86.3K 0.01% 498
2017
Q3 		$5.98M Sell
104,830
-134,677
-56% -$7.89M 0.02% 464
2017
Q2 		$14.4M Sell
239,507
-175,373
-42% -$9.99M 0.04% 305
2017
Q1 		$22.6M Buy
+414,880
New +$20.4M 0.06% 233

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Eaton Vance Management's BIVV Position: Q1 2018 in Review

Eaton Vance Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 103,253 shares — an estimated $5.57M sold.

Eaton Vance Management first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $22.6M in Q1 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Eaton Vance Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Eaton Vance Management sold 103,253 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $5.57M.
  • Eaton Vance Management first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • Eaton Vance Management's Bioverativ Inc. Common Stock position peaked at $22.6M in Q1 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Eaton Vance Management's 13F filing for Q1 2018, filed 7 May 2018.